Growth Hormone Receptor Antagonism Markedly Improves Chemotherapy Efficacy in Human Lung Cancer
Abstract
Pegvisomant is a Growth Hormone Receptor Antagonist (GHRA) that improves or sensitizes Human lung cancer to chemotherapy.
Keywords:
Growth Hormone, Pegvisomant, Lung Cancer, Chemotherapy, Translational Biomedical Sciences
Status
Graduate
Department
Translational Biomedical Sciences
College
Graduate College
Campus
Athens
Faculty Mentor
Kopchick, John
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
COinS
Growth Hormone Receptor Antagonism Markedly Improves Chemotherapy Efficacy in Human Lung Cancer
Pegvisomant is a Growth Hormone Receptor Antagonist (GHRA) that improves or sensitizes Human lung cancer to chemotherapy.